NCT07226323

Brief Summary

The goal of this clinical trial is to learn if the WeCare intervention-an adapted Friendship Bench program that integrates problem-solving therapy, minority-stress-informed content, and explicit PrEP/ART adherence skills-improves mental health and HIV medication adherence among men who have sex with men (MSM). It will also assess the safety, acceptability, and feasibility of delivering WeCare through trained lay coaches in community clinics. Main questions the trial aims to answer:

  • Does WeCare reduce symptoms of depression and anxiety among MSM?
  • Does WeCare improve PrEP and ART adherence and increase rates of viral suppression among participants on ART?
  • Is WeCare acceptable, feasible, and safe when delivered by lay coaches in POP INN clinics compared with usual care?

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable hiv-infections

Timeline
10mo left

Started Dec 2025

Shorter than P25 for not_applicable hiv-infections

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress36%
Dec 2025Apr 2027

First Submitted

Initial submission to the registry

November 7, 2025

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 10, 2025

Completed
21 days until next milestone

Study Start

First participant enrolled

December 1, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Last Updated

November 10, 2025

Status Verified

November 1, 2025

Enrollment Period

1.3 years

First QC Date

November 7, 2025

Last Update Submit

November 7, 2025

Conditions

Keywords

Men having sex with MenMedication adherencePrEP AdherenceART Adherence

Outcome Measures

Primary Outcomes (6)

  • Assessment : Modified version of the Session Evaluation Form (SEF) score

    13-item SEF measuring perceived feasibility, acceptability, and intervention utility. Composite scores are calculated with higher scores indicating more perceived feasibility and acceptability.

    Baseline, Month 3, Month 6

  • Change in Client Satisfaction Survey (CSQ-8) score

    8-item CSQ assessing satisfaction with recruitment, retention, and intervention procedures, engagement data from the trial (e.g., completion of sessions). Composite scores are calculated with higher scores indicating more satisfaction.

    Baseline, Month 3, Month 6

  • Mental health measures: Change in The Patient Health Questionnaire (PHQ-9) scores

    The Patient Health Questionnaire (PHQ-9) measures the frequency of depression symptoms within the past two weeks. The PHQ-9 comprises five categories, where a cut-off point of 0-4 indicates no depressive symptoms, 5-9 mild depressive symptoms, 10-14 moderate depressive symptoms, 15-19 moderately-severe depressive symptoms, and 20-27 severe depressive symptoms

    Baseline, Month 3, Month 6

  • Change in Psychological stress: WHO Self-Reporting Questionnaire-20 (SRQ-20) score

    The WHO Self-Reporting Questionnaire-20 (SRQ-20) includes items to reflect symptoms of depression, anxiety and psychosomatic complaints, which are all together grouped under the heading of common mental disorder (CMD) and have been found to detect probable mental health disorder with satisfactory accuracy

    Baseline, Month 3, Month 6

  • Change in ART adherence

    ART adherence will be defined as a suppressed HIV viral load (HIV-1 RNA viral load \<200 copies/mL) in a blood sample

    Baseline, Month 3, Month 6

  • Change in PrEP adherence

    PrEP adherence will be defined as an intracellular Tenofovir Diphosphate (TFV-DP) concentration ≥700 fmol/punch in a dried blood spot (DBS) sample. This concentration was found consistent with an average of ≥4 doses/week in the prior month in a directly observed study among men and women in the United States

    Baseline, Month 3, Month 6

Secondary Outcomes (2)

  • Self reported medication adherence

    Baseline, Month 3, Month 6

  • Status neutral composite adherence

    Baseline, Month 3, Month 6

Study Arms (2)

Friendship Bench (FB) arm

EXPERIMENTAL
Behavioral: WeCare

Control Arm

OTHER
Behavioral: Standard of Care

Interventions

WeCareBEHAVIORAL

The intervention is an adapted Friendship Bench (FB) for MSM in South Africa that integrates counseling on HIV medication adherence and the mental health-adherence relationship. The intervention includes up to 4 individual sessions and up to 4 group sessions; individual sessions may be delivered in person or online (Inuka-style), while all group sessions are in person.

Friendship Bench (FB) arm

The control group will receive enhanced standard care at POP INN Wellness Clinic: psychoeducation for all PrEP/ART enrollees, free medication, access to ongoing support groups, and referrals provided by the clinic.

Control Arm

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male
  • reports sexual intercourse with a man in the past 6 months
  • reside in the Johannesburg metropolitan area with no plans to relocate during the next 6 months
  • ability to communicate in English
  • current prescription for any ART regimen (HIV-positive participants) or daily oral PrEP (HIV-negative participants) at the POP INN clinic.
  • HIV positive participant only: unsuppressed HIV viral load (HIV-1 RNA viral load ≥200 copies/mL) in the sample collected in the past six months
  • HIV negative participants only: Self-reported challenges adhering to daily oral PrEP (i.e miss 3 or more tablets per week)
  • Moderate symptoms of depression during past 2 weeks (score on the PHQ-9 ≥10 and \<20)
  • Ability to understand and provide informed consent.

You may not qualify if:

  • Presently engaged in mental health therapy.
  • Participated in qualitative phase of WeCare study (AUR2-18-419) or open-pilot (present study).
  • Refuses audio recording of the in-person or online individual counselling session

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aurum Institute

Johannesburg, South Africa

Location

MeSH Terms

Conditions

HIV InfectionsPsychological Well-BeingMedication Adherence

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesPersonal SatisfactionBehaviorPatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth Behavior

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Don Operario, PhD

    Rollins School of Public Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Don Operario, PhD

CONTACT

Danielle Giovenco, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 7, 2025

First Posted

November 10, 2025

Study Start

December 1, 2025

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

April 1, 2027

Last Updated

November 10, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share

Data will be shared with researchers who submit a methodologically sound proposal. Data will be collected by Aurum; Aurum will share de-identified data with Emory (including data dictionaries).

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Data will be shared following publication

Locations